New AI Technology Can Determine Best Type of Cancer Treatment
By MedImaging International staff writers Posted on 23 Jan 2019 |
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
A team of researchers from Case Western Reserve University (Cleveland, OH, USA) is using artificial intelligence (AI) and smart-imaging computer technology for viewing routine medical images — MRIs, CAT scans, tissue biopsies — to determine the best type of cancer treatment.
In addition to detecting patterns beyond what the human eye can see, AI and computers can also determine the likelihood that a patient is going to respond to chemotherapy. A significant number of patients receive a cancer diagnosis, but also get over-treated and over-diagnosed. A recent study in the American Journal of Medicine found that 42% of new cancer patients lose their complete life savings in two years for treatment.
The researchers believe that a significant reduction can be brought about in the number of surgeries and of biopsies in patients who do not require them because they have benign nodules. Their research has been able to determine whether breast cancer patients, and more recently lung cancer patients, need chemotherapy. The technology would not reduce the number of jobs for pathologists or radiologists, but assist them and other clinicians.
Related Links:
Case Western Reserve University
In addition to detecting patterns beyond what the human eye can see, AI and computers can also determine the likelihood that a patient is going to respond to chemotherapy. A significant number of patients receive a cancer diagnosis, but also get over-treated and over-diagnosed. A recent study in the American Journal of Medicine found that 42% of new cancer patients lose their complete life savings in two years for treatment.
The researchers believe that a significant reduction can be brought about in the number of surgeries and of biopsies in patients who do not require them because they have benign nodules. Their research has been able to determine whether breast cancer patients, and more recently lung cancer patients, need chemotherapy. The technology would not reduce the number of jobs for pathologists or radiologists, but assist them and other clinicians.
Related Links:
Case Western Reserve University
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases